Influences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo
Authors:
- Tigris T.Y. LeeTLTigris T.Y. Lee
- Gustavo Linares-CruzGLGustavo Linares-Cruz
- Sabine FournierSFSabine Fournier
- Bruno de LigniéresBLBruno de Ligniéres
- 1 April 1995
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 63 (4) , 785-791
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Estrogen and progesterone receptor content in breast epithelial cells from healthy women during the menstrual cycleAmerican Journal of Obstetrics and Gynecology, 1993
- Toxicological and Pathological Applications of Proliferating Cell Nuclear Antigen (PCNA), A Novel Endogenous Marker for Cell ProliferationCritical Reviews in Toxicology, 1993
- Effects of progestins on the proliferation of estrogen-dependent human breast cancer cells under growth factor-defined conditionsThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- A possible mechanism for increased breast cell proliferation by progestins through increased reductive 17β‐hydroxysteroid dehydrogenase activityInternational Journal of Cancer, 1990
- The role of oestrogens and progestagens in the epidemiology and prevention of breast cancerEuropean Journal of Cancer and Clinical Oncology, 1988
- Hormone replacement therapy and breast cancerMaturitas, 1987
- Cyclin/PCNA is the auxiliary protein of DNA polymerase-δNature, 1987
- Cytometry of breast carcinoma: Significance of ploïdy balance and proliferation indexCytometry, 1987
- A Correlative Morphologic Study of Human Breast and Endometrium in the Menstrual CycleAmerican Journal of Surgical Pathology, 1986
- Automated Feulgen's Reaction in Auto-CytoscreeningThe Journal of the Japanese Society of Clinical Cytology, 1971